Skip to content

Study to Evaluate the Clinical Performance of Deseyne (Vifilcon C) Daily Disposable Soft Contact Lens

A Randomized, Active-Controlled, Open-Label Study to Evaluate the Clinical Performance of Deseyne (Vifilcon C) Daily Disposable Soft Contact Lens

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05927753
Enrollment
81
Registered
2023-07-03
Start date
2023-06-08
Completion date
2024-01-08
Last updated
2025-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Error - Myopia Bilateral

Brief summary

This clinical study is to provide clinical performance data comparing the test lens (Deseyne \[vifilcon C\] daily disposable soft contact lens) to a control lens (1-Day Acuvue Moist \[etafilcon A\] daily disposable soft contact lens) in the same indication for use (single use prior to removal followed by a fresh lens upon the next lens wear exposure). The study is designed to test the hypothesis that the test lens is substantially equivalent to the control lens in like indications for use.

Detailed description

A multicenter, randomized, active-controlled, open-label study design will be used to compare the clinical performance of the Deseyne (vifilcon C) test soft contact lens to the similarly indicated 1-Day Acuvue® Moist® (etafilcon A) control soft contact lens. Study participation is approximately 90 days in duration and will consist of approximately 80 subjects assigned in a 2:1 ratio to test or control lens bilaterally, respectively. Subjects must be otherwise healthy, with myopia between -1.00 D and -6.00 D and astigmatism no greater than 1.00 D that does not interfere with VA. At the Screening Visit, approximately two-thirds of the eligible subjects will be randomized to receive the test lens (Deseyne \[vifilcon C\] lenses) and the other one-third eligible subjects will be randomized to receive the control lens (1-Day Acuvue Moist \[etafilcon A\] lenses). At the Dispensing Visit (Visit 2), subjects will be provided with test or control lenses as part of the dispensing package, along with instructions for the use and care of the lenses. They will be recommended unpreserved lubricating/rewetting solution for use as needed during the study. Subjects will wear their assigned lenses bilaterally on a daily wear basis, for a minimum of 6 hours/day throughout the study (no maximum time is mandated, as long as subjects do not sleep in their lenses), with additional visits planned for 1 Week (Visit 3), 1 Month (Visit 4), 2 Months (Visit 5), and 3 Months/Exit Visit (Visit 6). This study follows United States Food and Drug Administration (FDA) Premarket Notification 510(k) Guidance for Daily Wear Contact Lenses adopted in May 1994, and any unpublished subsequent policy declarations.

Interventions

DEVICEDeseyne Daily Disposable Contact Lens (Test Device)

Comparison of contact lens performance between the test lens under study (Deseyne Daily Disposable Contact Lens) and the control lens f(1-Day Acuvue Moist Contact Lens) for safety and effectiveness.

Sponsors

Bruno Vision Care
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Masking description

Open label randomization assignment between test and control intervention.

Intervention model description

Comparison of a test contact lens performance to a known, cleared for market contact lens.

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. 18 to 40 years of age on the date the informed consent form (ICF) is signed 2. Presence of clear central corneas and absence of any anterior segment disorders in each eye 3. Presence of myopia and requirement for lens correction from -1.00 D to -6.00 D in each eye 4. Best-corrected distance visual acuity (BCDVA) of 50 ETDRS letters (0.1 logMAR) or better in each eye 5. Be an adapted soft contact lens wearer in each eye and agree to wear study lenses in each eye on a daily wear basis and not wear a non-study lens for approximately 3 months 6. Able and willing to comply with all treatment and follow-up/study procedures 7. Able to read, understand, and provide written informed consent on the IRB-approved ICF and provide authorization as appropriate for local privacy regulations

Exclusion criteria

1. Participation in any drug or device clinical investigation within 2 weeks prior to Screening and/or during the period of study participation 2. Women of childbearing potential (those who are not surgically sterilized or postmenopausal) who meet any of the following conditions: 1. Currently pregnant 2. Plans to become pregnant during the study 3. Currently breastfeeding 3. History of gas permeable lens wear in either eye within 30 days prior to Screening or history of polymethylmethacrylate lens wear in either eye within 3 months prior to Screening 4. Current monovision, multifocal, or toric contact lens wear in either eye 5. In either eye, current nonabsorbable punctal plug or implantation of absorbable punctal plug within 2 to 6 months (depending on type of absorbable plug) prior to Screening, or punctal plug removal within 2 months prior to Screening. Permanent punctal occlusion in 1 or more puncta or nasolacrimal duct obstruction in either eye is excluded 6. Use of any prescription ocular medication throughout the duration of the study. Prescription eyedrops for dry eye disease (eg, Restasis, Xiidra, Cequa, Eysuvis), as well as nasally administered Tyrvaya, must be discontinued 2 weeks prior to Screening and are prohibited throughout the duration of the study Clinical Study Protocol Version 3.0, 26 April 2023 Page 17 of 66 Bruno Vision Care Protocol 22001 7. Use of over-the-counter eyedrops (eg, oxymetazoline, naphazoline, ketotifen, etc.), except for unpreserved lubricant eyedrops or artificial tears (eg, Systane, Refresh), within 1 week prior to Screening and throughout the duration of the study 8. Use of any systemic or topical medications that may, in the Investigator's opinion, affect ocular physiology or lens performance 9. Anisometropia (spherical equivalent) \>2.00 D 10. Ocular astigmatism \>1.00 D in either eye 11. Amblyopia in either eye 12. Aphakia in either eye 13. Active ocular disease (eg, dry eye disease, blepharitis, conjunctivitis, keratitis, etc.) in either eye. Subjects must be symptom free for at least 7 days 14. History or evidence of ocular infection within 30 days prior to Screening 15. History or evidence of ocular herpes simplex or ocular herpes zoster 16. Any grade corneal infiltrates in either eye 17. Grade ≥2 finding in either eye during slit lamp examination 18. Any Present finding in either eye during slit lamp examination that, in the Investigator's opinion, may interfere with contact lens wear 19. Any scar or neovascularization within the central 4 mm of the cornea in either eye. Subjects with minor peripheral corneal scarring (not extending into the central area) that, in the Investigator's opinion, does not interfere with contact lens wear are eligible to participate in this study 20. History of any corneal surgery (eg, refractive surgery or therapeutic) in either eye 21. Any systemic disease currently affecting ocular health or which, in the Investigator's opinion, may have an effect on ocular health in either eye during the course of the study 22. Allergy to any component in the study care products 23. Meet any of the following criteria: 1. Subject is an employee of the investigative site 2. Subject or a member of the subject's household is an ophthalmologist, an optometrist, an optician, or an ophthalmic assistant/technician 3. Subject or a member of the subject's household is an employee of a manufacturer of contact lenses or contact lens care products 4. Subject or a member of the subject's household is an employee of a market research firm -

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeBaseline, Day 1, Week 1, Month 1, Month 2, Month 3To assess each eye for the change from baseline to each post-baseline visit in distance logMAR VA (letters read)
Number and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineDay 1, Week 1, Month 1, Month 2, Month 3To assess the number and percentage of subjects with no more than 5 letters read loss from baseline
Slit Lamp Findings Grade >2 at Any Follow-Up Visit3 monthsTo assess the following slit lamp findings: epithelial edema, epithelial microcysts, limbal injection, bulbar injection, upper lid tarsal conjunctival, corneal neovascularization, and corneal infiltrates

Secondary

MeasureTime frameDescription
Symptoms/ComplaintsMonth 3This unnamed questionnaire measures change from baseline in discomfort, excessive tearing, photophobia, halos, itching/burning/spectacle blur, variable vision, blurred vision, lens needs cleaning, handling using a 0 (no symptoms) to 4 (severe symptoms) scale for each symptom
Lens Wettability, Centration, and Movement3 monthsWettability Analog Scale 0-4 (0=100% wettable, 4=more than one dry spot greater than 0.5 mm) Lower score is better Centration Analog Scale 0-4 (0=superior cornea, 4=inferior cornea) Lower score is better Movement Analog Scale 0-4 (0=adequate, 4=adherence to cornea) Lower score is better
Lens Deposits3 monthsTo assess type of deposit

Countries

United States

Participant flow

Recruitment details

81 subjects enrolled in the study for a period of 3 months follow-up. Study began on April 8, 2023 at three clinical sites and was completed on January 8, 2024. All sites were at private clinical optometric sites.. Each site conducted screening evaluation to determine eligibility for continuation in the study. Follow-up visits were scheduled at 1 week, 1 month, 2 months, and 3 months including he exit visit. Subjects were instructed to wear the contact lenses a minimum of 6 hours per day.

Pre-assignment details

The study was designed as a randomized enrollment dictated by an electronic randomization program to test and control. This assignment took place at the screening visit at each site. All subjects were subject to review for inclusion and exclusion at enrollment screening visit. To be included/excluded all screening needed to meet all criteria by forced choice selection. Any positive exclusion element excluded the subject from continuing with participation.

Participants by arm

ArmCount
Test Lens. Deseyne Daily Disposable Contact Lens
Test contact lens to be worn as a daily disposable soft (hydrophilic) contact lens, to be discarded daily. Individual new lens placed daily for a period of 90 consecutive days, bilaterally. Follow-up visits are 1 week, 1 month, 2 months, and 3 months after dispensing. Deseyne Daily Disposable Contact Lens (Test Device): Comparison of contact lens performance between the test lens under study (Deseyne Daily Disposable Contact Lens) and the control lens f(1-Day Acuvue Moist Contact Lens) for safety and effectiveness.
53
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact Lens
Control lens to be worn as a daily disposable soft (hydrophilic) contact lens, to be discarded daily, Individual new lens placed daily for a period of 90 consecutive days, bilaterally. Follow-up visits are 1 week, 1 month, 2 months, and 3 months after dispensing. Deseyne Daily Disposable Contact Lens (Test Device): Comparison of contact lens performance between the test lens under study (Deseyne Daily Disposable Contact Lens) and the control lens f(1-Day Acuvue Moist Contact Lens) for safety and effectiveness.
28
Total81

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyPhysician Decision01
Overall StudyWithdrawal by Subject02

Baseline characteristics

CharacteristicTotalTest Lens. Deseyne Daily Disposable Contact LensControl Lens. 1-Day Acuvue Moist Daily Disposable Contact Lens
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
81 Participants53 Participants28 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
2 Participants1 Participants1 Participants
Race (NIH/OMB)
Black or African American
8 Participants4 Participants4 Participants
Race (NIH/OMB)
More than one race
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
70 Participants47 Participants23 Participants
Region of Enrollment
United States
81 participants53 participants28 participants
Sex: Female, Male
Female
57 Participants39 Participants18 Participants
Sex: Female, Male
Male
24 Participants14 Participants10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 530 / 26
other
Total, other adverse events
3 / 531 / 26
serious
Total, serious adverse events
0 / 530 / 26

Outcome results

Primary

Change From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by Eye

To assess each eye for the change from baseline to each post-baseline visit in distance logMAR VA (letters read)

Time frame: Baseline, Day 1, Week 1, Month 1, Month 2, Month 3

Population: Each row refers to either right eyes (OD) or left eyes (OS); therefore, the number of eyes analyzed is one-half of the total eyes in the study.

ArmMeasureGroupValue (MEAN)Dispersion
Test Lens. Deseyne Daily Disposable Contact LensChange From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeChange from baseline at Day 1 OD0.3 letters readStandard Deviation 2.76
Test Lens. Deseyne Daily Disposable Contact LensChange From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeChange from baseline at Day 1 OS-0.0 letters readStandard Deviation 2.19
Test Lens. Deseyne Daily Disposable Contact LensChange From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeChange from baseline at Week 1 OS-0.1 letters readStandard Deviation 2.79
Test Lens. Deseyne Daily Disposable Contact LensChange From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeChange from baseline at Month 2 OD0.7 letters readStandard Deviation 2.85
Test Lens. Deseyne Daily Disposable Contact LensChange From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeChange from baseline at Month 1 OS0.3 letters readStandard Deviation 2.17
Test Lens. Deseyne Daily Disposable Contact LensChange From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeChange from baseline at Month 1 OD0.5 letters readStandard Deviation 2.71
Test Lens. Deseyne Daily Disposable Contact LensChange From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeChange from baseline at Month 2 OS0.3 letters readStandard Deviation 2.7
Test Lens. Deseyne Daily Disposable Contact LensChange From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeChange from baseline at Month 3 OD0.3 letters readStandard Deviation 3.14
Test Lens. Deseyne Daily Disposable Contact LensChange From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeChange from baseline at Month 3 OS-0.1 letters readStandard Deviation 2.84
Test Lens. Deseyne Daily Disposable Contact LensChange From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeChange from baseline at Week 1 OD0.4 letters readStandard Deviation 2.55
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensChange From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeChange from baseline at Month 3 OS0.5 letters readStandard Deviation 2.52
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensChange From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeChange from baseline at Week 1 OD0.4 letters readStandard Deviation 1.94
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensChange From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeChange from baseline at Day 1 OS0.2 letters readStandard Deviation 2.56
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensChange From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeChange from baseline at Day 1 OD0.0 letters readStandard Deviation 2.47
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensChange From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeChange from baseline at Month 1 OD0.4 letters readStandard Deviation 2.83
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensChange From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeChange from baseline at Month 2 OD0.5 letters readStandard Deviation 2.38
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensChange From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeChange from baseline at Month 3 OD-0.4 letters readStandard Deviation 2.81
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensChange From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeChange from baseline at Week 1 OS0.5 letters readStandard Deviation 2.12
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensChange From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeChange from baseline at Month 1 OS0.4 letters readStandard Deviation 2.86
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensChange From Baseline to Each Post-Baseline Visit in Distance logMAR Visual Acuity (Letters Read) by EyeChange from baseline at Month 2 OS0.8 letters readStandard Deviation 2.58
Primary

Number and Percentage of Subjects With No More Than 5 Letters Read Loss From Baseline

To assess the number and percentage of subjects with no more than 5 letters read loss from baseline

Time frame: Day 1, Week 1, Month 1, Month 2, Month 3

ArmMeasureGroupValue (NUMBER)
Test Lens. Deseyne Daily Disposable Contact LensNumber and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineDay 1 OS100 percentage of subjects
Test Lens. Deseyne Daily Disposable Contact LensNumber and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineWeek 1 OS98.1 percentage of subjects
Test Lens. Deseyne Daily Disposable Contact LensNumber and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineMonth 1 OD98.1 percentage of subjects
Test Lens. Deseyne Daily Disposable Contact LensNumber and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineMonth 1 OS100 percentage of subjects
Test Lens. Deseyne Daily Disposable Contact LensNumber and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineDay 1 OD98.1 percentage of subjects
Test Lens. Deseyne Daily Disposable Contact LensNumber and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineMonth 2 OS100 percentage of subjects
Test Lens. Deseyne Daily Disposable Contact LensNumber and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineMonth 2 OD98.1 percentage of subjects
Test Lens. Deseyne Daily Disposable Contact LensNumber and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineMonth 3 OS98.1 percentage of subjects
Test Lens. Deseyne Daily Disposable Contact LensNumber and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineWeek 1 OD100 percentage of subjects
Test Lens. Deseyne Daily Disposable Contact LensNumber and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineMonth 3 OD94.3 percentage of subjects
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensNumber and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineMonth 3 OS96.0 percentage of subjects
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensNumber and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineWeek 1 OD100 percentage of subjects
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensNumber and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineMonth 1 OD96.0 percentage of subjects
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensNumber and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineMonth 2 OD100 percentage of subjects
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensNumber and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineDay 1 OS96.2 percentage of subjects
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensNumber and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineWeek 1 OS100 percentage of subjects
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensNumber and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineMonth 1 OS96.0 percentage of subjects
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensNumber and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineMonth 2 OS96.0 percentage of subjects
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensNumber and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineDay 1 OD100 percentage of subjects
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensNumber and Percentage of Subjects With No More Than 5 Letters Read Loss From BaselineMonth 3 OD96.0 percentage of subjects
Primary

Slit Lamp Findings Grade >2 at Any Follow-Up Visit

To assess the following slit lamp findings: epithelial edema, epithelial microcysts, limbal injection, bulbar injection, upper lid tarsal conjunctival, corneal neovascularization, and corneal infiltrates

Time frame: 3 months

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Test Lens. Deseyne Daily Disposable Contact LensSlit Lamp Findings Grade >2 at Any Follow-Up VisitNo slit lamp findings Grade >253 Participants
Test Lens. Deseyne Daily Disposable Contact LensSlit Lamp Findings Grade >2 at Any Follow-Up VisitAny slit lamp findings Grade >20 Participants
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSlit Lamp Findings Grade >2 at Any Follow-Up VisitAny slit lamp findings Grade >20 Participants
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSlit Lamp Findings Grade >2 at Any Follow-Up VisitNo slit lamp findings Grade >226 Participants
Secondary

Lens Deposits

To assess type of deposit

Time frame: 3 months

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Test Lens. Deseyne Daily Disposable Contact LensLens DepositsNo deposits51 Participants
Test Lens. Deseyne Daily Disposable Contact LensLens DepositsFilm0 Participants
Test Lens. Deseyne Daily Disposable Contact LensLens DepositsSpots2 Participants
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensLens DepositsNo deposits22 Participants
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensLens DepositsFilm1 Participants
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensLens DepositsSpots2 Participants
Secondary

Lens Wettability, Centration, and Movement

Wettability Analog Scale 0-4 (0=100% wettable, 4=more than one dry spot greater than 0.5 mm) Lower score is better Centration Analog Scale 0-4 (0=superior cornea, 4=inferior cornea) Lower score is better Movement Analog Scale 0-4 (0=adequate, 4=adherence to cornea) Lower score is better

Time frame: 3 months

Population: Each row analyzes either right eyes (OS) or left eyes (OS); therefore, the total number of eyes in a row is one-half of the total eye population for that arm.

ArmMeasureGroupValue (MEAN)Dispersion
Test Lens. Deseyne Daily Disposable Contact LensLens Wettability, Centration, and MovementChange from baseline in wettability OD0.1 units on a scaleStandard Deviation 0.32
Test Lens. Deseyne Daily Disposable Contact LensLens Wettability, Centration, and MovementChange from baseline in wettability OS0.1 units on a scaleStandard Deviation 0.32
Test Lens. Deseyne Daily Disposable Contact LensLens Wettability, Centration, and MovementChange from baseline in centration OD0.1 units on a scaleStandard Deviation 0.36
Test Lens. Deseyne Daily Disposable Contact LensLens Wettability, Centration, and MovementChange from baseline in centration OS0.1 units on a scaleStandard Deviation 0.4
Test Lens. Deseyne Daily Disposable Contact LensLens Wettability, Centration, and MovementChange from baseline in movement OD0.0 units on a scaleStandard Deviation 0.39
Test Lens. Deseyne Daily Disposable Contact LensLens Wettability, Centration, and MovementChange from baseline in movement OS0.1 units on a scaleStandard Deviation 0.45
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensLens Wettability, Centration, and MovementChange from baseline in centration OD0.0 units on a scaleStandard Deviation 0.61
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensLens Wettability, Centration, and MovementChange from baseline in wettability OD0.1 units on a scaleStandard Deviation 0.33
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensLens Wettability, Centration, and MovementChange from baseline in movement OD0.0 units on a scaleStandard Deviation 0.35
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensLens Wettability, Centration, and MovementChange from baseline in wettability OS0.1 units on a scaleStandard Deviation 0.28
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensLens Wettability, Centration, and MovementChange from baseline in centration OS0.0 units on a scaleStandard Deviation 0.73
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensLens Wettability, Centration, and MovementChange from baseline in movement OS0.0 units on a scaleStandard Deviation 0.35
Secondary

Symptoms/Complaints

This unnamed questionnaire measures change from baseline in discomfort, excessive tearing, photophobia, halos, itching/burning/spectacle blur, variable vision, blurred vision, lens needs cleaning, handling using a 0 (no symptoms) to 4 (severe symptoms) scale for each symptom

Time frame: Month 3

Population: Each row analyzes either right eyes (OD) or left eyes (OS); therefore, the number of eyes analyzed is one-half of the total eye population in that arm

ArmMeasureGroupValue (MEAN)Dispersion
Test Lens. Deseyne Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in blurred vision OD0.0 units on a scaleStandard Deviation 0.19
Test Lens. Deseyne Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in handling OS0.6 units on a scaleStandard Deviation 1.05
Test Lens. Deseyne Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in halos OD0.0 units on a scaleStandard Deviation 0
Test Lens. Deseyne Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in excessive tearing OD0.0 units on a scaleStandard Deviation 0
Test Lens. Deseyne Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in itching/burning OD-0.0 units on a scaleStandard Deviation 0.5
Test Lens. Deseyne Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in discomfort OS0.6 units on a scaleStandard Deviation 0.79
Test Lens. Deseyne Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in itching/burning OS0.0 units on a scaleStandard Deviation 0.52
Test Lens. Deseyne Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in halos OS0.0 units on a scaleStandard Deviation 0
Test Lens. Deseyne Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in spectacle blur OD0.0 units on a scaleStandard Deviation 0
Test Lens. Deseyne Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in variable vision OD0.1 units on a scaleStandard Deviation 0.45
Test Lens. Deseyne Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in photophobia OD0.0 units on a scaleStandard Deviation 0
Test Lens. Deseyne Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in discomfort OD0.6 units on a scaleStandard Deviation 0.8
Test Lens. Deseyne Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in blurred vision OS0.1 units on a scaleStandard Deviation 0.33
Test Lens. Deseyne Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in spectacle blur OS0.0 units on a scaleStandard Deviation 0
Test Lens. Deseyne Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in lens needs cleaning OD0.0 units on a scaleStandard Deviation 0.19
Test Lens. Deseyne Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in photophobia OS0.0 units on a scaleStandard Deviation 0
Test Lens. Deseyne Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in lens needs cleaning OS0.0 units on a scaleStandard Deviation 0.19
Test Lens. Deseyne Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in variable vision OS0.1 units on a scaleStandard Deviation 0.45
Test Lens. Deseyne Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in handling OD0.5 units on a scaleStandard Deviation 1.07
Test Lens. Deseyne Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in excessive tearing OS0.0 units on a scaleStandard Deviation 0
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in handling OD0.4 units on a scaleStandard Deviation 0.87
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in discomfort OD0.4 units on a scaleStandard Deviation 0.96
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in discomfort OS0.4 units on a scaleStandard Deviation 0.96
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in excessive tearing OS0.0 units on a scaleStandard Deviation 0
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in photophobia OD-0.1 units on a scaleStandard Deviation 0.4
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in photophobia OS-0.1 units on a scaleStandard Deviation 0.41
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in halos OD-0.1 units on a scaleStandard Deviation 0.4
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in halos OS-0.1 units on a scaleStandard Deviation 0.41
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in spectacle blur OD0.0 units on a scaleStandard Deviation 0
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in spectacle blur OS0.0 units on a scaleStandard Deviation 0
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in variable vision OS0.1 units on a scaleStandard Deviation 0.28
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in handling OS0.5 units on a scaleStandard Deviation 0.88
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in itching/burning OD0.1 units on a scaleStandard Deviation 0.4
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in itching/burning OS0.1 units on a scaleStandard Deviation 0.5
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in variable vision OD0.1 units on a scaleStandard Deviation 0.28
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in blurred vision OD0.2 units on a scaleStandard Deviation 0.62
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in blurred vision OS0.2 units on a scaleStandard Deviation 0.62
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in lens needs cleaning OD-0.0 units on a scaleStandard Deviation 0.2
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in lens needs cleaning OS-0.0 units on a scaleStandard Deviation 0.2
Control Lens. 1-Day Acuvue Moist Daily Disposable Contact LensSymptoms/ComplaintsChange from baseline in excessive tearing OD0.0 units on a scaleStandard Deviation 0

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026